The CXCL12/CXCR4/ACKR3 Response Axis in Chronic Neurodegenerative Disorders of the Central Nervous System: Therapeutic Target and Biomarker
Authors:
- 12 June 2021
- journal article
- review article
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 42 (7) , 2147-2156
Abstract
There has been an increase in the incidence of chronic neurodegenerative disorders of the central nervous system, including Alzheimer’s and Parkinson’s diseases, over the recent years mostly due to the rise in the number of elderly individuals. In addition, various neurodegenerative disorders are related to imbalances in the CXCL12/CXCR4/ACKR3 response axis. Notably, the CXC Chemokine Ligand 12 (CXCL12) is essential for the development of the central nervous system. Moreover, the expression and distribution of CXCL12 and its receptors are associated with the aggravation or alleviation of symptoms of neurodegenerative disorders. Therefore, the current review sought to highlight the specific functions of CXCL12 and its receptors in various neurodegenerative disorders, in order to provide new insights for future research.Keywords
Funding Information
- National Natural Science Foundation of China (81471809, 81971639)
- Natural Science Foundation of Liaoning Province (2019-ZD-0772)
This publication has 72 references indexed in Scilit:
- CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunityJournal of Experimental Medicine, 2011
- Adult SVZ Lineage Cells Home to and Leave the Vascular Niche via Differential Responses to SDF1/CXCR4 SignalingCell Stem Cell, 2010
- Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic interventionNeurobiology of Disease, 2010
- β-arrestin- but not G protein-mediated signaling by the “decoy” receptor CXCR7Proceedings of the National Academy of Sciences, 2009
- Pathological Expression of CXCL12 at the Blood-Brain Barrier Correlates with Severity of Multiple SclerosisThe American Journal of Pathology, 2008
- Multiple roles of chemokine CXCL12 in the central nervous system: A migration from immunology to neurobiologyProgress in Neurobiology, 2008
- Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7Proceedings of the National Academy of Sciences, 2007
- Differential processing of stromal-derived factor-1α and stromal-derived factor-1β explains functional diversityBlood, 2004
- NF-κB, chemokine gene transcription and tumour growthNature Reviews Immunology, 2002
- The Biology of Chemokines and their ReceptorsAnnual Review of Immunology, 2000